Structure-guided development of potent pfpkg inhibitors for malaria chemoprotection

Active Cooperative Agreement Awarded Last action

Award ID
HT94252320023
Recipient
Awarding agency
Obligated
$2,024,907

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 82% complete
Place of performance
Newark, NJ 07107, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

This $2,024,907.00 Cooperative Agreement award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the "STRUCTURE-GUIDED DEVELOPMENT OF POTENT PFPKG INHIBITORS FOR MALARIA CHEMOPROTECTION" project led by Rutgers, The State University of New Jersey (Rutgers), doing business as RBHS-School of Nursing. The project aims to conduct research and development to create new malaria prevention treatments. As the prime awardee, Rutgers will provide the necessary research, expertise, and resources to advance the development of potent PfPKG inhibitors for malaria chemoprotection over the 4-year period from July 2023 to July 2027.

Quick answers

Who received award HT94252320023?

HT94252320023 was awarded to Rutgers The State University Of New Jersey by Defense Health Agency (Department of Defense) on July 15, 2023.

How much is award HT94252320023 worth?

$2,024,907 has been obligated on HT94252320023.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login